282 related articles for article (PubMed ID: 25282251)
1. Prosthetic replacement of the ocular surface ecosystem as treatment for ocular surface disease in patients with a history of Stevens-Johnson syndrome/toxic epidermal necrolysis.
Papakostas TD; Le HG; Chodosh J; Jacobs DS
Ophthalmology; 2015 Feb; 122(2):248-53. PubMed ID: 25282251
[TBL] [Abstract][Full Text] [Related]
2. Vision-related function after scleral lens fitting in ocular complications of Stevens-Johnson syndrome and toxic epidermal necrolysis.
Tougeron-Brousseau B; Delcampe A; Gueudry J; Vera L; Doan S; Hoang-Xuan T; Muraine M
Am J Ophthalmol; 2009 Dec; 148(6):852-9.e2. PubMed ID: 19837383
[TBL] [Abstract][Full Text] [Related]
3. Prosthetic Replacement of the Ocular Surface Ecosystem Treatment for Ocular Surface Disease in Pediatric Patients With Stevens-Johnson Syndrome.
Wang Y; Rao R; Jacobs DS; Saeed HN
Am J Ophthalmol; 2019 May; 201():1-8. PubMed ID: 30664843
[TBL] [Abstract][Full Text] [Related]
4. Tear exchangeable limbal rigid contact lens for ocular sequelae resulting from Stevens-Johnson syndrome or toxic epidermal necrolysis.
Sotozono C; Yamauchi N; Maeda S; Kinoshita S
Am J Ophthalmol; 2014 Nov; 158(5):983-93. PubMed ID: 25036881
[TBL] [Abstract][Full Text] [Related]
5. Prosthetic replacement of the ocular surface ecosystem scleral lens therapy for patients with ocular symptoms of chronic Stevens-Johnson syndrome.
Heur M; Bach D; Theophanous C; Chiu GB
Am J Ophthalmol; 2014 Jul; 158(1):49-54. PubMed ID: 24699156
[TBL] [Abstract][Full Text] [Related]
6. The relation between visual performance and clinical ocular manifestations in Stevens-Johnson syndrome.
Kaido M; Yamada M; Sotozono C; Kinoshita S; Shimazaki J; Tagawa Y; Hara Y; Chikama T; Tsubota K
Am J Ophthalmol; 2012 Sep; 154(3):499-511.e1. PubMed ID: 22818907
[TBL] [Abstract][Full Text] [Related]
7. Stevens-Johnson Syndrome and Corneal Ectasia: Management and a Case for Association.
Saeed HN; Kohanim S; Le HG; Chodosh J; Jacobs DS
Am J Ophthalmol; 2016 Sep; 169():276-281. PubMed ID: 27386788
[TBL] [Abstract][Full Text] [Related]
8. The role of systemic immunomodulatory treatment and prognostic factors on chronic ocular complications in Stevens-Johnson syndrome.
Kim DH; Yoon KC; Seo KY; Lee HS; Yoon SC; Sotozono C; Ueta M; Kim MK
Ophthalmology; 2015 Feb; 122(2):254-64. PubMed ID: 25262319
[TBL] [Abstract][Full Text] [Related]
9. Visual improvement after cultivated oral mucosal epithelial transplantation.
Sotozono C; Inatomi T; Nakamura T; Koizumi N; Yokoi N; Ueta M; Matsuyama K; Miyakoda K; Kaneda H; Fukushima M; Kinoshita S
Ophthalmology; 2013 Jan; 120(1):193-200. PubMed ID: 23084239
[TBL] [Abstract][Full Text] [Related]
10. Chronic Ocular Sequelae of Stevens-Johnson Syndrome in Children: Long-term Impact of Appropriate Therapy on Natural History of Disease.
Basu S; Shanbhag SS; Gokani A; Kedar R; Bahuguna C; Sangwan VS
Am J Ophthalmol; 2018 May; 189():17-28. PubMed ID: 29421293
[TBL] [Abstract][Full Text] [Related]
11. Clinical benefits of the Boston Ocular Surface Prosthesis.
Stason WB; Razavi M; Jacobs DS; Shepard DS; Suaya JA; Johns L; Rosenthal P
Am J Ophthalmol; 2010 Jan; 149(1):54-61. PubMed ID: 19878920
[TBL] [Abstract][Full Text] [Related]
12. Prosthetic Replacement of the Ocular Surface Ecosystem (PROSE) scleral device compared to keratoplasty for the treatment of corneal ectasia.
DeLoss KS; Fatteh NH; Hood CT
Am J Ophthalmol; 2014 Nov; 158(5):974-82. PubMed ID: 25058902
[TBL] [Abstract][Full Text] [Related]
13. Ocular Manifestations of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Children.
Catt CJ; Hamilton GM; Fish J; Mireskandari K; Ali A
Am J Ophthalmol; 2016 Jun; 166():68-75. PubMed ID: 27018234
[TBL] [Abstract][Full Text] [Related]
14. Lid-Related Keratopathy in Stevens-Johnson Syndrome: Natural Course and Impact of Therapeutic Interventions in Children and Adults.
Shanbhag SS; Shah S; Singh M; Bahuguna C; Donthineni PR; Basu S
Am J Ophthalmol; 2020 Nov; 219():357-365. PubMed ID: 32681905
[TBL] [Abstract][Full Text] [Related]
15. Long-term effect of corneoscleral contact lenses on refractory ocular surface diseases.
Lee SM; Kim YJ; Choi SH; Oh JY; Kim MK
Cont Lens Anterior Eye; 2019 Aug; 42(4):399-405. PubMed ID: 30389416
[TBL] [Abstract][Full Text] [Related]
16. Clinical trial to evaluate the therapeutic benefits of limbal-supported contact lens wear for ocular sequelae due to Stevens-Johnson syndrome/toxic epidermal necrolysis.
Itoi M; Ueta M; Ogino K; Sumi E; Imai K; Teramukai S; Kinoshita S; Sotozono C
Cont Lens Anterior Eye; 2020 Dec; 43(6):535-542. PubMed ID: 32513522
[TBL] [Abstract][Full Text] [Related]
17. Indications and outcomes of amniotic membrane transplantation in the management of acute stevens-johnson syndrome and toxic epidermal necrolysis: a case-control study.
Hsu M; Jayaram A; Verner R; Lin A; Bouchard C
Cornea; 2012 Dec; 31(12):1394-402. PubMed ID: 23135531
[TBL] [Abstract][Full Text] [Related]
18. PROSE therapy used to minimize corneal trauma in patients with corneal epithelial defects.
Ling JD; Gire A; Pflugfelder SC
Am J Ophthalmol; 2013 Apr; 155(4):615-619, 619.e1-2. PubMed ID: 23218704
[TBL] [Abstract][Full Text] [Related]
19. Fluid filled scleral contact lens in pediatric patients: challenges and outcome.
Rathi VM; Mandathara PS; Vaddavalli PK; Srikanth D; Sangwan VS
Cont Lens Anterior Eye; 2012 Aug; 35(4):189-92. PubMed ID: 22459875
[TBL] [Abstract][Full Text] [Related]
20. Effect of age and early intervention with a systemic steroid, intravenous immunoglobulin or amniotic membrane transplantation on the ocular outcomes of patients with Stevens-Johnson syndrome.
Kim KH; Park SW; Kim MK; Wee WR
Korean J Ophthalmol; 2013 Oct; 27(5):331-40. PubMed ID: 24082770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
